Reuters

US FDA finds control lapses at Moderna manufacturing pl...

Reuters exclusively reported that U.S. drug regulators in September found qualit...

Lilly to build $2.5 billion Germany plant as obesity dr...

Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant i...

Cigna explores shedding Medicare Advantage business 

Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is explo...

Edwards Lifesciences cooperating with EU antitrust regu...

Reuters exclusively reported that US medical device maker Edwards Lifesciences, ...

Bayer’s new CEO plans to cut management jobs in prelude...

Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut manage...

Novo Nordisk says experimental drug amycretin show 13% ...

Reuters was first to report on the early trial data for Novo Nordisk’s highly an...

Major Bayer shareholder Harris backs CEO’s focus on int...

Reuters exclusively reported that major Bayer shareholder Harris Associates came...

Eli Lilly could launch obesity drug in India next year

Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to laun...

ECB sounds out lenders on exposure to Spanish drugmaker...

Reuters exclusively reported that the European Central Bank was asking banks to ...

US FDA approves first drug for fatty liver disease NASH

Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.